...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine
【24h】

Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine

机译:基于新型载体凝胶核心脂质体的阻断传播疟疾疫苗的研制与表征

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of present work was to investigate the potential utility of novel carrier gel core liposomes for intramuscular delivery of transmission blocking malaria antigen Pfs25 and to evaluate the effect of coadministration of vaccine adjuvant CpGODN on immune enhancement of recombinant protein antigen Pfs25.In the present work we have prepared gel core liposomes containing core of biocompatible polymer poly acrylic acid in phospholipid bilayer by reverse phase evaporation method and characterized for various in vitro parameters. In process stability of the encapsulated antigen was evaluated by SDS-PAGE followed by western blotting. The immune stimulating ability was studied by measuring anti-Pfs25 antibody titer in serum of Balb/c mice following intramuscular administration of various formulations. A Significant and perdurable immune responses was obtained after intramuscular administration of gel core liposomes encapsulated Pfs25 as compared to Pfs25 loaded conventional liposomes. Moreover co-administration of CpGODN in liposomes (conventional and gel core) was found to further increase the immunogenicity of vaccine. The result indicates high potential of gel core liposomes for their use as a carrier adjuvant for intramuscular delivery of recombinant antigen Pfs25 based transmission blocking malaria vaccine.
机译:本工作的目的是研究新型载体凝胶核心脂质体在肌肉内传递阻断传播疟疾抗原Pfs25的潜在效用,并评估疫苗佐剂CpGODN共同给药对重组蛋白抗原Pfs25免疫增强的影响。我们通过反相蒸发法制备了在磷脂双层中含有生物相容性聚合物聚丙烯酸核的凝胶核脂质体,并针对各种体外参数进行了表征。在过程中,通过SDS-PAGE,然后进行蛋白质印迹,评估了包封的抗原的稳定性。肌肉注射各种制剂后,通过测量Balb / c小鼠血清中的抗Pfs25抗体滴度,研究了免疫刺激能力。与负载Pfs25的常规脂质体相比,肌肉内注射封装的Pfs25的凝胶核心脂质体后,可获得显着且持久的免疫反应。此外,还发现在脂质体(常规和凝胶核心)中共同施用CpGODN可进一步提高疫苗的免疫原性。结果表明,凝胶核心脂质体作为载体佐剂用于肌内递送基于重组抗原Pfs25的传播阻断疟疾疫苗的潜力很大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号